oa Molecular Diagnosis and Vaccines - Prevalence of TT virus infection among hemodialysis patients
|Article Title||Prevalence of TT virus infection among hemodialysis patients|
|© Publisher:||Egyptian Association of Immunologists|
|Journal||Molecular Diagnosis and Vaccines|
|Affiliations||1 *Microbiology and Immunology Department, Faculty of Medicine, Al-Azhar University, **Internal Medicine Department Faculty of Medicine, Al-Azhar University & ***Tropical Medicine Department, Faculty of Medicine, Al-Azhar University|
|Publication Date||Jan 2005|
|Pages||69 - 76|
|Keyword(s)||blood transfusion, DNA virus, hemodialysis, Hepatitis, hepatotropic virus, liver disease and TT virus|
The TT virus (TTV) is a DNA virus which was first identified in patients with non-A to -G hepatitis following blood transfusion. Sera from 100 attendees of hemodialysis (HD) unit of Al-Hussain University Hospital were tested for the presence of anti-HCV, HCV-RNA using nested polymerase chain reaction ""PCR"" with primers directed to the highly conserved 5' non-coding region of the HCV genome and TTV genome by nested-PCR using the primers of the open reading frame 1 (ORF). The overall prevalence of anti-HCV was 38 % from which only 22% were positive for HCV-RNA. TTV viremia was found in 26%, the prevalence of TTV infection was higher in patients with previous blood transfusion (18/26) and in those with diabetes mellitus (23/26). No significant relationship was found between TTV viremia and hepatitis C virus, age, sex, and duration of HD treatment. These findings support that TTV viremia is widespread among hemodialysis patients and can be detected in 26 % since no viremic patient had clinical or biochemical signs of liver disease.
Article metrics loading...